We tested the effects of nimodipine upon neurologic outcome in 31 cats subjected to 14 minutes of cardiac arrest followed by resuscitation. With the dose schedule used, nimodipine had no effect upon neurologic outcome or upon the percentage of ischemic neurons in frontal, hippocampal, occipital, or cerebellar brain sections. 12 ' 13 The calcium entry blocker nimodipine improves neurologic outcome when administered after neck tourniquet-induced global cerebral ischemia in primates, and those investigators proposed a clinical trial of nimodipine administration in patients resuscitated from cardiac arrest.
Materials and Methods
The protocol was approved by our Institutional Review Board. We studied 40 colony-bred cats, aged 4-6 months and weighing 1.9-3.3 kg. They received only water ad libitum for 16-20 hours prior to study. The cats were anesthetized with 4% halothane in O 2 delivered into a Plexiglas box. Peripheral venous cannulas were placed in both forelegs, and 0.3 mg/kg i.v. pancuronium was administered to facilitate intubation with a 4.0 mm i.d. cuffed endotracheal tube. Inspired halothane was decreased 1.0-1.5% in 70% N 2 O and the balance O 2 . In the supine position, the cats were mechanically ventilated with a tidal volume of 15 ml/kg, 5 cm H 2 O positive end-expiratory pressure (PEEP), and their respiratory rates were adjusted to maintain normocarbia (Paco 2 30-35 mm Hg). Esophageal temperature (maintained at 37.5° C with a heating pad and lamp), electrocardiogram (ECG) (lead II), end-tidal CO 2 (Accucap OJCO2 Monitor, Datascope, Paramus, New Jersey), and end-tidal halothane concentration (Anesthetic Agent Monitor 222, PuritanBennet, Wilmington, Massachusetts) were continuously monitored. The electroencephalogram (EEG) was recorded from fronto-occipital (Fz-Oz) and biparietal (C3-C4) leads at a gain of 50 /xV/7 mm with filter settings for low and high frequency of 1 and 30 Hz, respectively (Model 78, Grass, Quincy, Massachusetts). Cats received an infusion of 4 ml/kg/hr normal saline and 0.5 mg/hr pancuronium.
Using aseptic technique and after skin infiltration with 1 ml of 0.25% bupivacaine, cannulas were inserted into the distal abdominal aorta and the right atrium via the left femoral artery and vein, respectively. A wire (0.025 in. in diameter) was inserted with its tip protruding 2-5 mm beyond the distal end of the atrial cannula; its placement was confirmed by ECG. The mean arterial blood pressure (MAP), right atrial pressure (RAP) (both referenced to the level of the right atrium), ECG, and EEG were continuously recorded on a polygraph recorder (Model 2758, Hewlett-Packard, Waltham, Massachusetts). After closure of the groin wound, inspired halothane was decreased to 0.5% and the cat was left undisturbed for 30 minutes.
Procedures for cardiac arrest and resuscitation were performed as described by Todd et al 14 with minor modifications. After the 30-minute equilibration period, arterial blood gases and pH (IL-813, Instrumentation Laboratories, Lexington, Massachusetts), MAP, RAP, and heart rate were measured and halothane was discontinued. Plasma glucose (Glucose Analyzer 23A, Yellow Springs Instrument Co., Yellow Springs, Ohio), hematocrit, and plasma electrolytes (Na/K Ion Analyzer, Nova Biomedical, Waltham, Massachusetts) (in 14 cats) were also measured. One minute after discontinuation of halothane, ventricular fibrillation was induced by passing a 20-V, 60-Hz alternating current between the right atrial wire and the subcutaneous precordial needle. Ventilation was simultaneously discontinued, and the endotracheal tube was occluded. The fibrillating voltage was tapered to 0 V during the first minute of the arrest period. However, if spontaneous defibrillation occurred during the first minute, the voltage was increased to 20 V and the tapering was repeated over an additional minute. Cats with any spontaneous heart beat >1 minute into the arrest period were discarded. Four minutes into the arrest period, the wire and subcutaneous needle were removed. At 13.5 minutes, mechanical ventilation was resumed with 100% O 2 at a respiratory rate 50% above the prearrest level. Exactly 14 minutes after the induction of ventricular fibrillation (0 minutes postresuscitation [PR]), closed-chest cardiac compressions (CPR) were initiated. The thorax was compressed between the lateral walls of the rib cage at a rate of 100-120 compressions/min. Efforts were made to maintain systolic blood pressure at >100 mm Hg and diastolic blood pressure at >50 mm Hg. Sodium bicarbonate (1.0 meq/kg) and epinephrine (15 Mg/kg) were injected via the atrial cannula simultaneously with the initiation of CPR. After 1 minute of CPR, a 15-J DC shock was applied between two chest paddles (DC Defibrillator 640, Physiocontrol, Redmond, Washington) placed on the shaved lateral chest walls. Every 60 seconds, sodium bicarbonate and epinephrine in the same doses as above and a 25-J DC shock were repeated until defibrillation occurred (to a maximum of four repetitions). All cats received 25 Mg/kg atropine and 1 mg/kg lidocaine at 3 minutes PR or after restoration of a spontaneous heart beat.
Resuscitation was considered successful if systolic blood pressure was maintained at > 100 mm Hg without CPR by 4 minutes PR. Following successful resuscitation, the cats were randomly divided into two treatment groups. All laboratory personnel were blinded to the treatment regimen. Beginning at 5 minutes PR, cats received either nimodipine (10 Mg/kg over 2 minutes followed by 2 /xg/kg/min for 10 hours) or the same volume of placebo; the solvent for nimodipine was ethanol and polyethylene glycol as supplied by Miles Laboratories, West Haven, Connecticut. The cats were maintained in an intensive care setting until 24-30 hours PR. Controlled ventilation was continued, with muscle paralysis provided by pancuronium. To minimize the stress of immobilization, midazolam (0.5 mg/kg i.v. bolus followed by 0.5 mg/kg/hr infusion) was started at 1 hour PR, by which time all the cats had regained continuous EEG activity. The inspired gas mixture was changed to 40% O 2 in N 2 at 3 hours PR. All cats received 5 cm H 2 O PEEP, which was increased to 10 cm H 2 O as needed to maintain Pao 2 at >100 mm Hg. MAP, RAP, end-tidal CO 2 , ECG, and EEG were continuously monitored and arterial blood gases and chemistries were intermittently analyzed during the intensive care period.
MAP was maintained at 80-120 mm Hg. Hypotension (MAP of <80 mm Hg) was treated by incremental administration of 10 ml lactated Ringer's solution (total not to exceed 30 ml) and, if needed, an infusion of norepinephrine (NE). Hypertension (MAP of > 120 mm Hg) was treated by an infusion of trimethaphan (TMP). Metabolic and respiratory acidosis were corrected by administration of additional bicarbonate (1-meq increments) and by an increase in respiratory rate, respectively. The maintenance fluid was changed to 5% dextrose in 0.45% NaCl solution at 6 hours PR. The cats were turned and their tracheas were suctioned every 4 hours. Cefazolin (50 mg i.m.) was administered at the end of surgery and every 12 hours until 48 hours PR.
At 20 hours PR, the infusion of pancuronium and midazolam was discontinued. After spontaneous muscle activity was observed, 60 Mg/kg i.v. neostigmine and 40 Mg/kg > v -atropine were administered to reverse any residual muscle relaxant effect and to avoid bradycardia, respectively. Each cat was extubated after Paco 2 was maintained at <40 mm Hg during spontaneous ventilation. The arterial and atrial cannulas were removed (1-1.5% halothane in O 2 by mask as needed). If the cat did not regain spontaneous respiration, mechanical ventilation was continued for the next 6 hours without muscle paralysis or sedation, and a repeated trial of spontaneous ventilation was attempted. Each extubated cat was placed in a Plexiglas cage with the ambient temperature maintained at 25° C. O 2 (5 1/min) was supplied until 48 hours PR. An infusion of 5% dextrose in 0.45% NaCl was continued until 48 hours PR. Thereafter, strained baby food and water were given by mouth or via gastric tube as indicated. If needed, 40-60 ml/kg/day maintenance fluids were injected subcutaneously until 96 hours PR.
Arterial blood gases and pH were measured at 6 minutes PR, every 15 minutes until 1 hour PR, every hour until 6 hours PR, and every 2 hours until 24 hours PR (or until the cannulas were removed). Hematocrit and plasma glucose concentration were examined at 6 minutes PR, at 1 hour PR, and then every 4 hours. Plasma electrolytes were examined at 6 minutes PR and at 1, 4, 12, and 24 hours PR. The total volume of blood sampled from each cat averaged 20-22 ml over 24 hours. After the 96-hour observation, the cats were anesthetized with 30 mg/kg i.p. pentobarbital and were perfusion-fixed with 10% buffered formalin phosphate solution injected via the left ventricle. The brains were removed and placed in a 10% formalin solution for at least 2 weeks prior to histologic examination.
Neurologic function was examined at 48 and 96 hours PR by two observers blinded to treatment group using a modification of the neurologic deficit score scale described by Todd et al 14 (Table 1) . Cats were graded according to their level of consciousness, respiratory pattern, cranial nerve responses, muscle tone, motor responses to noxious stimuli, behavioral reactions, stance, and gait. A score of 0 indicates a normal cat and 100 a brain-dead cat. For statistical analysis, the scores awarded by each observer were averaged and this mean value was used as the neurologic deficit score (NDS) for each cat.
Neuropathologic examination was performed in the following manner. Coronal slices of the left frontal cortex, occipital cortex, and hippocampus and parasagittal and horizontal sections of the left cerebellum were dehydrated in a graded series of alcohols, cleared in xylene, and embedded in paraffin. Sections were cut 6 fim thick and stained with hematoxylin and eosin. The histologic sections were evaluated by two observers blinded to treatment group and NDS. Ischemic neurons were identified by the presence of shrunken, eosinophilic cytoplasm and homogeneous, pyknotic, or fragmented nuclei. Histologic sections were graded on a scale of 0 to 3 according to the frequency of ischemic neurons in defined regions of each section. For the neocortical regions, 0 indicates normal neurons, 1 rare (10%) ischemic neurons, 2 frequent (10-50%) ischemic neurons, and 3 a majority (>50%) ischemic neurons. A similar scale was used for the cerebellum, where the number of ischemic Purkinje cells was evaluated, but a different scale was used for the hippocampal sections to consider regional differences in sensitivity to ischemia within the hippocampus, as well as diffuse or overall damage. All regions of the hippocampal formation (dentate gyrus, hippocampus proper, and subiculum) were evaluated, and an overall score of 0-3 was awarded using the following scale: 0, normal; 1, rare ischemic pyramidal or granule cells; 2, scattered rare ischemic neurons plus focal, more severe ischemic damage; 3, severe, diffuse ischemic damage. The total score for each cat was the sum of the scores from each region (i.e., frontal cortex, occipital cortex, hippocampus, and cerebellum) and ranged from 0 to 12. The neuropathologic score (NPS) was the mean of the total scores awarded by each observer.
Cats were excluded from data analysis if any of the following occurred: prearrest plasma glucose concentration of > 180 mg/dl, any spontaneous heart beat >1 minute into the arrest period, CPR lasting >4 minutes, Pao 2 of <70 mm Hg and/or Paco 2 of >50 mm Hg for >30 minutes, MAP of <70 or > 130 mm Hg for >60 minutes and MAP of <50 mm Hg at any time, or evidence for a noncerebral cause of Data are mean±SD. MAP, mean arterial blood pressure; RAP, right atrial pressure; HR, heart rate; Na, plasma sodium concentration; K, plasma potassium concentration; P, placebo; N, nimodipine. n = 15 for P, n = 16 except as noted.
*Or time cannulas were removed. 1, 0.05, respectively, different from P.
in all cats except for one nimodipine-treated and two placebo-treated cats that required a fourth shock for conversion to a sinus rhythm. The resuscitation time (144±35 vs. 157±42 seconds), number of DC shocks, and total dose of drugs used during CPR did not differ significantly between groups. Table 2 shows values for representative physiologic variables in the groups. There were no differences before arrest. After spontaneous cardiac rhythm was restored, MAP promptly returned to near prearrest values. This was followed by a brief period of hypertension (data not shown), which necessitated TMP infusion for a short while (<15 minutes) in most cats. MAP was maintained between 80 and 120 mm Hg in both groups after resuscitation. Despite this, MAP in the nimodipine group was significantly less than that in the placebo group at 30 minutes, 1 hour, and 8 hours PR. The total dose of NE was significantly greater and the dose of TMP was significantly less than in the nimodipine group than in the placebo group (Table 3 ). The total volume of lactated Ringer's solution administered did not differ significantly between groups. There were no significant differences in arterial blood gases between groups except for a decreased pH in the nimodipine group at 1 hour PR. In both groups, plasma glucose concentration increased after resuscitation and remained elevated until 24 hours PR, but plasma glucose concentration was significantly greater in the nimodipine group than in the placebo death (i.e., pulmonary edema, pneumonia, cardiac failure, etc.).
Physiologic variables were compared between groups with unpaired t tests. The Mann-Whitney rank sum test was used to identify group differences in NDS and NPS. Correlations between NDS and NPS were evaluated by Spearman's rank sum coefficient. All data are presented as mean±SD;p<0.05 was considered significant.
Results
Nine cats were excluded from analysis: one because of elevated prearrest plasma glucose concentration, four because CPR lasted >4 minutes, one for technical reasons (pressure transducer erroneously calibrated), one died between 36 and 48 hours PR, and two could not be weaned from ventilatory support by 30 hours PR (causes undetermined). A total of 31 cats (16 nimodipine-treated and 15 placebo-treated) were entered into analysis.
The groups were well matched for body weight (2.34±0.24 vs. 2.33±0.35 kg), sex (12 males and four females vs. 12 males and three females), time of halothane anesthesia (113±18 vs. 115±15 minutes), and end-tidal halothane concentration immediately before arrest (0.54±0.07% vs. 0.57±0.07%). Pulsatile blood pressure disappeared instantaneously with the fibrillating current, and all cats had an isoelectric EEG 2 minutes after the onset of ventricular fibrillation. Two or three DC shocks were necessary group at 4, 8, and 12 hours PR. There were no significant differences in hematocrit between groups except for an unexplained lower hematocrit in the placebo group at 12 hours PR. There were no significant differences in plasma electrolytes between groups at any time. Two patterns of EEG recovery were distinguished: recovery with continuous slow activity and recovery with bursts of 5-10 Hz activity mixed with periods of suppression. In cats with the latter pattern, bursts were apparent after the return of continuous EEG activity but gradually disappeared by 1-2 hours PR. There were no significant differences between groups in the frequency with which the burst-suppression pattern was observed (10 of 16 vs. 11 of 15 cats) or in the time to first appearance of any EEG activity, although continuous EEG activity reappeared significantly earlier in the nimodipine group (Table 3) . There was no correlation between the EEG recovery pattern or EEG recovery time and either NDS or NPS. No clinical or EEG evidence of seizure activity was noted during the study.
There were no significant differences between groups in NDS at 48 (23±16 for nimodipine vs. 30±15 for placebo, p=0.28) or 96 hours PR (16±16 for nimodipine vs. 20±16 for placebo, />=0.23) (Figure 1 ). All cats had a normal level of consciousness but behavioral and/or gait abnormalities at 96 hours PR. There were no differences in NPS between groups (5.8±2.4 for nimodipine vs. 6.5±2.3 for placebo,/?=0.59). Figure 2 shows the distribution of neuropathologic scores in each of the four regions examined for each group. There were no significant differences between groups in any region examined. There was a significant correlation between NPS rank and 96-hour NDS rank (/?<0.001) (Figure 3 ). There were no significant correlations between NDS and MAP at each sampling time, plasma glucose concentration, NE dose, or TMP dose. Interobserver variability for NDS and NPS was small (r=0.99).
Discussion
In the present circumstances, nimodipine had no beneficial effect upon neurologic or neuropathologic outcome following 14 minutes of cardiac arrest in cats. Our results are in contrast to those of a previous report that indicated a beneficial effect of nimodipine in attenuating brain injury following 17 minutes of complete cerebral ischemia in primates. 12 There are obvious differences between these two studies, including animal species and the methods of inducing cerebral ischemia (cardiac arrest vs. neck tourniquet inflation with systemic hypotension). Steen et al 12 found no significant differences in MAP at the three sampling times reported, and in contrast to our study, found no differences in the total dose or duration of administration of either TMP or NE. Compared with the cardiac arrest model involving total body ischemia, the neck tourniquet model of complete cerebral ischemia involves relatively minor cardiovascular insult. The cardiac arrest model may cause disturbances of such magnitude in multiple organ systems (i.e., ischemia of the spinal cord, liver, and bowel) in addition to the brain that any positive effects of nimodipine may be difficult to observe. Despite this, we believe that the cardiac arrest model is relevant to use in simulating the clinical situation of complete cerebral ischemia during cardiac arrest. Nimodipine infused at a rate half that we used (1 /ig/kg/min) has been reported to improve postischemic cerebral blood flow in dogs without vasopressor support, even though it significantly decreased MAP. 8 In light of the cardiovascular depressive effects of nimodipine, we were faced with a number of experimental protocol decisions. To maximize any beneficial effect of nimodipine, we sought to administer the largest dose tolerated. Consequently, we selected a dose of nimodipine by identifying the maximum dose associated with stable systemic hemodynamics in normal cats. In normal animals, MAP decreased by approximately 20% but remained above 100 mm Hg without vasopressors after a bolus dose of 10 /itg/kg nimodipine followed by a nimodipine infusion of 2 /Ltg/kg/min. However, in most cats resuscitated from 14 minutes of cardiac arrest, with the same regimen of nimodipine administration, blood pressure support with NE was necessary to maintain MAP above 80 mm Hg. Despite treatment with NE, MAP was still significantly less in our nimodipine group than in our placebo group at 30 minutes, 1 hour, and 8 hours PR. It has been reported that mild hypotension induced by phlebotomy (MAP < 90 mm Hg) negates the beneficial effects of nimodipine on EEG recovery and reperfusion (colloidal carbon filling) following regional cerebral ischemia in cats. 4 Thus, we cannot exclude the possibility that differences in MAP between groups may have affected neurologic outcome. The effects of NE and TMP on postischemic brain are not known with certainty. However, in a rat model of forebrain ischemia, TMP administered at the onset of transient ischemia was reported to exacerbate pathologic lesions, while NE administered during reperfusion attenuated pathologic lesions. 15 If these findings are applicable to our study, then TMP and NE administered to the placebo and nimodipine groups, respectively, would have exaggerated rather than attenuated any beneficial effects of nimodipine in terms of NDS and NPS.
Plasma glucose level increased significantly immediately after resuscitation in both groups, with significantly greater values in the nimodipine group at 4, 8, and 12 hours PR. The explanation for this difference is unclear. Catecholamines are known to cause hyperglycemia via cyclic adenosine monophosphate-induced increases in glycogenolysis and gluconeogenesis. 16 Preischemic hyperglycemia has been reported to aggravate histologic lesions and impair neurologic recovery following forebrain ischemia in rats 17 or global cerebral ischemia in primates, 18 possibly as a result of increased cerebral lactate production. Administration of glucosecontaining solutions during ischemia has been shown to significantly impair neurologic recovery following global brain ischemia in rats. 19 However, in a rat forebrain ischemia experiment, early postischemic differences in blood glucose concentration did not influence outcome. 17 Given these results of previous studies, the differences in plasma glucose content we observed several hours after resuscitation, while possibly related to differences in NE administration, appear unlikely to have influenced neurologic recovery. Calcium blockade by magnesium 20 is known to increase plasma glucose concentrations. However, the effects of other calcium entry blockers, including nimodipine, on plasma glucose concentration have not been studied.
The EEG recovery patterns were identical to those previously reported by Todd et al. 14 However, contrary to their reports, the EEG recovery pattern did not correlate with final neurologic outcome, although the significantly earlier return of continuous EEG activity in the nimodipine group could represent a transient cerebral effect of nimodipine.
In conclusion, postresuscitation treatment with nimodipine following 14 minutes of cardiac arrest did not improve neurologic outcome in cats. The possibility that more rigid control of blood pressure or a lower dose of nimodipine would have resulted in improvement cannot be excluded. However, we speculate that the beneficial effect of nimodipine, if any, is small and that its cardiovascular actions may negate this effect in the clinical setting. To finally determine the effects of calcium entry blockers upon neurologic outcome following cardiac arrest, additional studies with tighter control of MAP will be necessary.
